Epilepsy therapy development: Technical and methodologic issues in studies with animal models

Aristea S. Galanopoulou, Merab Kokaia, Jeffrey A. Loeb, Astrid Nehlig, Asla Pitkänen, Michael A. Rogawski, Kevin J. Staley, Vicky H. Whittemore, F. Edward Dudek

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The search for new treatments for seizures, epilepsies, and their comorbidities faces considerable challenges. This is due in part to gaps in our understanding of the etiology and pathophysiology of most forms of epilepsy. An additional challenge is the difficulty in predicting the efficacy, tolerability, and impact of potential new treatments on epilepsies and comorbidities in humans, using the available resources. Herein we provide a summary of the discussions and proposals of the Working Group 2 as presented in the Joint American Epilepsy Society and International League Against Epilepsy Translational Workshop in London (September 2012). We propose methodologic and reporting practices that will enhance the uniformity, reliability, and reporting of early stage preclinical studies with animal seizure and epilepsy models that aim to develop and evaluate new therapies for seizures or epilepsies, using multidisciplinary approaches. The topics considered include the following: (1) implementation of better study design and reporting practices; (2) incorporation Wiley Periodicals, Inc.

Original languageEnglish (US)
Pages (from-to)13-23
Number of pages11
JournalEpilepsia
Volume54
Issue numberSUPPL.4
DOIs
StatePublished - Aug 2013

Fingerprint

Epilepsy
Animal Models
Seizures
Comorbidity
Therapeutics
Joints
Education

Keywords

  • Infrastructure.
  • Nonpharmacological treatment
  • Pharmacokinetics
  • Regulatory requirements
  • Tolerability
  • Video-electroencephalography

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

Galanopoulou, A. S., Kokaia, M., Loeb, J. A., Nehlig, A., Pitkänen, A., Rogawski, M. A., ... Dudek, F. E. (2013). Epilepsy therapy development: Technical and methodologic issues in studies with animal models. Epilepsia, 54(SUPPL.4), 13-23. https://doi.org/10.1111/epi.12295

Epilepsy therapy development : Technical and methodologic issues in studies with animal models. / Galanopoulou, Aristea S.; Kokaia, Merab; Loeb, Jeffrey A.; Nehlig, Astrid; Pitkänen, Asla; Rogawski, Michael A.; Staley, Kevin J.; Whittemore, Vicky H.; Dudek, F. Edward.

In: Epilepsia, Vol. 54, No. SUPPL.4, 08.2013, p. 13-23.

Research output: Contribution to journalArticle

Galanopoulou, AS, Kokaia, M, Loeb, JA, Nehlig, A, Pitkänen, A, Rogawski, MA, Staley, KJ, Whittemore, VH & Dudek, FE 2013, 'Epilepsy therapy development: Technical and methodologic issues in studies with animal models', Epilepsia, vol. 54, no. SUPPL.4, pp. 13-23. https://doi.org/10.1111/epi.12295
Galanopoulou, Aristea S. ; Kokaia, Merab ; Loeb, Jeffrey A. ; Nehlig, Astrid ; Pitkänen, Asla ; Rogawski, Michael A. ; Staley, Kevin J. ; Whittemore, Vicky H. ; Dudek, F. Edward. / Epilepsy therapy development : Technical and methodologic issues in studies with animal models. In: Epilepsia. 2013 ; Vol. 54, No. SUPPL.4. pp. 13-23.
@article{a4f7a33b59af40b79e06b7ea2e1f3e56,
title = "Epilepsy therapy development: Technical and methodologic issues in studies with animal models",
abstract = "The search for new treatments for seizures, epilepsies, and their comorbidities faces considerable challenges. This is due in part to gaps in our understanding of the etiology and pathophysiology of most forms of epilepsy. An additional challenge is the difficulty in predicting the efficacy, tolerability, and impact of potential new treatments on epilepsies and comorbidities in humans, using the available resources. Herein we provide a summary of the discussions and proposals of the Working Group 2 as presented in the Joint American Epilepsy Society and International League Against Epilepsy Translational Workshop in London (September 2012). We propose methodologic and reporting practices that will enhance the uniformity, reliability, and reporting of early stage preclinical studies with animal seizure and epilepsy models that aim to develop and evaluate new therapies for seizures or epilepsies, using multidisciplinary approaches. The topics considered include the following: (1) implementation of better study design and reporting practices; (2) incorporation Wiley Periodicals, Inc.",
keywords = "Infrastructure., Nonpharmacological treatment, Pharmacokinetics, Regulatory requirements, Tolerability, Video-electroencephalography",
author = "Galanopoulou, {Aristea S.} and Merab Kokaia and Loeb, {Jeffrey A.} and Astrid Nehlig and Asla Pitk{\"a}nen and Rogawski, {Michael A.} and Staley, {Kevin J.} and Whittemore, {Vicky H.} and Dudek, {F. Edward}",
year = "2013",
month = "8",
doi = "10.1111/epi.12295",
language = "English (US)",
volume = "54",
pages = "13--23",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Wiley-Blackwell",
number = "SUPPL.4",

}

TY - JOUR

T1 - Epilepsy therapy development

T2 - Technical and methodologic issues in studies with animal models

AU - Galanopoulou, Aristea S.

AU - Kokaia, Merab

AU - Loeb, Jeffrey A.

AU - Nehlig, Astrid

AU - Pitkänen, Asla

AU - Rogawski, Michael A.

AU - Staley, Kevin J.

AU - Whittemore, Vicky H.

AU - Dudek, F. Edward

PY - 2013/8

Y1 - 2013/8

N2 - The search for new treatments for seizures, epilepsies, and their comorbidities faces considerable challenges. This is due in part to gaps in our understanding of the etiology and pathophysiology of most forms of epilepsy. An additional challenge is the difficulty in predicting the efficacy, tolerability, and impact of potential new treatments on epilepsies and comorbidities in humans, using the available resources. Herein we provide a summary of the discussions and proposals of the Working Group 2 as presented in the Joint American Epilepsy Society and International League Against Epilepsy Translational Workshop in London (September 2012). We propose methodologic and reporting practices that will enhance the uniformity, reliability, and reporting of early stage preclinical studies with animal seizure and epilepsy models that aim to develop and evaluate new therapies for seizures or epilepsies, using multidisciplinary approaches. The topics considered include the following: (1) implementation of better study design and reporting practices; (2) incorporation Wiley Periodicals, Inc.

AB - The search for new treatments for seizures, epilepsies, and their comorbidities faces considerable challenges. This is due in part to gaps in our understanding of the etiology and pathophysiology of most forms of epilepsy. An additional challenge is the difficulty in predicting the efficacy, tolerability, and impact of potential new treatments on epilepsies and comorbidities in humans, using the available resources. Herein we provide a summary of the discussions and proposals of the Working Group 2 as presented in the Joint American Epilepsy Society and International League Against Epilepsy Translational Workshop in London (September 2012). We propose methodologic and reporting practices that will enhance the uniformity, reliability, and reporting of early stage preclinical studies with animal seizure and epilepsy models that aim to develop and evaluate new therapies for seizures or epilepsies, using multidisciplinary approaches. The topics considered include the following: (1) implementation of better study design and reporting practices; (2) incorporation Wiley Periodicals, Inc.

KW - Infrastructure.

KW - Nonpharmacological treatment

KW - Pharmacokinetics

KW - Regulatory requirements

KW - Tolerability

KW - Video-electroencephalography

UR - http://www.scopus.com/inward/record.url?scp=84891679696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891679696&partnerID=8YFLogxK

U2 - 10.1111/epi.12295

DO - 10.1111/epi.12295

M3 - Article

C2 - 23909850

AN - SCOPUS:84891679696

VL - 54

SP - 13

EP - 23

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - SUPPL.4

ER -